Trial · NCT05011058
Participant flow56
How many started, completed or left each group, period by period.
1 to 20 of 56
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Diffuse Large B-Cell Lymphoma | 9 | |
| Overall Study | STARTED | Extranodal Natural Killer/T-Cell Lymphoma | 11 | |
| Overall Study | STARTED | Peripheral T-Cell Lymphoma (Combination Therapy) | 38 | |
| Overall Study | STARTED | Peripheral T-Cell Lymphoma (Monotherapy) | 10 | |
| Overall Study | STARTED | Hodgkin Lymphoma | 8 | |
| Overall Study | STARTED | Post-Transplant Lymphoproliferative Disorders | 3 | |
| Overall Study | STARTED | Human Immunodeficiency Virus-Associated Lymphomas | 3 | |
| Overall Study | STARTED | Other EBV-Positive Lymphomas | 20 | |
| Overall Study | Stage 1 | Diffuse Large B-Cell Lymphoma | 9 | |
| Overall Study | Stage 1 | Extranodal Natural Killer/T-Cell Lymphoma | 11 | |
| Overall Study | Stage 1 | Peripheral T-Cell Lymphoma (Combination Therapy) | 10 | |
| Overall Study | Stage 1 | Peripheral T-Cell Lymphoma (Monotherapy) | 10 | |
| Overall Study | Stage 1 | Hodgkin Lymphoma | 8 | |
| Overall Study | Stage 1 | Post-Transplant Lymphoproliferative Disorders | 3 | |
| Overall Study | Stage 1 | Human Immunodeficiency Virus-Associated Lymphomas | 3 | |
| Overall Study | Stage 1 | Other EBV-Positive Lymphomas | 20 | |
| Overall Study | Stage 2 | Diffuse Large B-Cell Lymphoma | 0 | |
| Overall Study | Stage 2 | Extranodal Natural Killer/T-Cell Lymphoma | 0 | |
| Overall Study | Stage 2 | Peripheral T-Cell Lymphoma (Combination Therapy) | 11 | |
| Overall Study | Stage 2 | Peripheral T-Cell Lymphoma (Monotherapy) | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05011058/flow